310 related articles for article (PubMed ID: 35495127)
21. The Role of DOT1L in Normal and Malignant Hematopoiesis.
Arnold O; Barbosa K; Deshpande AJ; Zhu N
Front Cell Dev Biol; 2022; 10():917125. PubMed ID: 35712672
[TBL] [Abstract][Full Text] [Related]
22. DOT1L and H3K79 Methylation in Transcription and Genomic Stability.
Wood K; Tellier M; Murphy S
Biomolecules; 2018 Feb; 8(1):. PubMed ID: 29495487
[TBL] [Abstract][Full Text] [Related]
23. Antiproliferative and Antimigration Activities of Fluoro-Neplanocin A via Inhibition of Histone H3 Methylation in Triple-Negative Breast Cancer.
Byun WS; Kim WK; Yoon JS; Jarhad DB; Jeong LS; Lee SK
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32244385
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of histone H3K79 methylation selectively inhibits proliferation, self-renewal and metastatic potential of breast cancer.
Zhang L; Deng L; Chen F; Yao Y; Wu B; Wei L; Mo Q; Song Y
Oncotarget; 2014 Nov; 5(21):10665-77. PubMed ID: 25359765
[TBL] [Abstract][Full Text] [Related]
25. [DOT1: a distinct class of histone lysine methyltransferase].
Gao WL; Liu HL
Yi Chuan; 2007 Dec; 29(12):1449-54. PubMed ID: 18065378
[TBL] [Abstract][Full Text] [Related]
26. Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.
Deshpande AJ; Chen L; Fazio M; Sinha AU; Bernt KM; Banka D; Dias S; Chang J; Olhava EJ; Daigle SR; Richon VM; Pollock RM; Armstrong SA
Blood; 2013 Mar; 121(13):2533-41. PubMed ID: 23361907
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma.
Bourguignon LY; Wong G; Shiina M
J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147
[TBL] [Abstract][Full Text] [Related]
28. DOT1L histone methyltransferase regulates the expression of BCAT1 and is involved in sphere formation and cell migration of breast cancer cell lines.
Oktyabri D; Ishimura A; Tange S; Terashima M; Suzuki T
Biochimie; 2016 Apr; 123():20-31. PubMed ID: 26783998
[TBL] [Abstract][Full Text] [Related]
29. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells.
Steger DJ; Lefterova MI; Ying L; Stonestrom AJ; Schupp M; Zhuo D; Vakoc AL; Kim JE; Chen J; Lazar MA; Blobel GA; Vakoc CR
Mol Cell Biol; 2008 Apr; 28(8):2825-39. PubMed ID: 18285465
[TBL] [Abstract][Full Text] [Related]
30. The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness.
Kari V; Raul SK; Henck JM; Kitz J; Kramer F; Kosinsky RL; Übelmesser N; Mansour WY; Eggert J; Spitzner M; Najafova Z; Bastians H; Grade M; Gaedcke J; Wegwitz F; Johnsen SA
Clin Epigenetics; 2019 Jan; 11(1):4. PubMed ID: 30616689
[TBL] [Abstract][Full Text] [Related]
31. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
Rau RE; Rodriguez BA; Luo M; Jeong M; Rosen A; Rogers JH; Campbell CT; Daigle SR; Deng L; Song Y; Sweet S; Chevassut T; Andreeff M; Kornblau SM; Li W; Goodell MA
Blood; 2016 Aug; 128(7):971-81. PubMed ID: 27335278
[TBL] [Abstract][Full Text] [Related]
32. Selective inhibitors of histone methyltransferase DOT1L: design, synthesis, and crystallographic studies.
Yao Y; Chen P; Diao J; Cheng G; Deng L; Anglin JL; Prasad BV; Song Y
J Am Chem Soc; 2011 Oct; 133(42):16746-9. PubMed ID: 21936531
[TBL] [Abstract][Full Text] [Related]
33. Histone methyltransferase Dot1L plays a role in postembryonic development in Xenopus tropicalis.
Wen L; Fu L; Guo X; Chen Y; Shi YB
FASEB J; 2015 Feb; 29(2):385-93. PubMed ID: 25366346
[TBL] [Abstract][Full Text] [Related]
34. ES cell cycle progression and differentiation require the action of the histone methyltransferase Dot1L.
Barry ER; Krueger W; Jakuba CM; Veilleux E; Ambrosi DJ; Nelson CE; Rasmussen TP
Stem Cells; 2009 Jul; 27(7):1538-47. PubMed ID: 19544450
[TBL] [Abstract][Full Text] [Related]
35. Structural Basis of Dot1L Stimulation by Histone H2B Lysine 120 Ubiquitination.
Valencia-Sánchez MI; De Ioannes P; Wang M; Vasilyev N; Chen R; Nudler E; Armache JP; Armache KJ
Mol Cell; 2019 Jun; 74(5):1010-1019.e6. PubMed ID: 30981630
[TBL] [Abstract][Full Text] [Related]
36. Primitive Erythropoiesis in the Mouse is Independent of DOT1L Methyltransferase Activity.
Malcom CA; Ratri A; Piasecka-Srader J; Borosha S; Chakravarthi VP; Alvarez NS; Vivian JL; Fields TA; Karim Rumi MA; Fields PE
Front Cell Dev Biol; 2021; 9():813503. PubMed ID: 35111761
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic drug library screening reveals targeting DOT1L abrogates NAD
Gu X; Hua Y; Yu J; Yang L; Ge S; Jia R; Chai P; Zhuang A; Fan X
J Pharm Anal; 2023 Jan; 13(1):24-38. PubMed ID: 36820078
[TBL] [Abstract][Full Text] [Related]
38. Structural Basis for Recognition of Ubiquitylated Nucleosome by Dot1L Methyltransferase.
Anderson CJ; Baird MR; Hsu A; Barbour EH; Koyama Y; Borgnia MJ; McGinty RK
Cell Rep; 2019 Feb; 26(7):1681-1690.e5. PubMed ID: 30759380
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the DNA damage response and gene expression by the Dot1L histone methyltransferase and the 53Bp1 tumour suppressor.
FitzGerald J; Moureau S; Drogaris P; O'Connell E; Abshiru N; Verreault A; Thibault P; Grenon M; Lowndes NF
PLoS One; 2011 Feb; 6(2):e14714. PubMed ID: 21383990
[TBL] [Abstract][Full Text] [Related]
40. CBP mediated DOT1L acetylation confers DOT1L stability and promotes cancer metastasis.
Liu C; Yang Q; Zhu Q; Lu X; Li M; Hou T; Li Z; Tang M; Li Y; Wang H; Yang Y; Wang H; Zhao Y; Wen H; Liu X; Mao Z; Zhu WG
Theranostics; 2020; 10(4):1758-1776. PubMed ID: 32042335
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
